British pharmaceutical company, Clinova, is travelling to South Africa this year to showcase its leading range of soluble hydration tablets.
Africa Health 2014 in Johannesburg is the largest healthcare exhibition in the Sub-Saharan region and attracts over 400 international companies and 5,000 attendees. This year’s exhibition will run from 29-31 May and Clinova can be found at Stand 2J26.
Clinova is a pharmaceutical company focused on developing, manufacturing and marketing innovative, cost-effective healthcare products and medical devices.
At the exhibition, Clinova will showcase its leading range of Hydration Tablets based on a scientifically balanced formula of electrolytes, glucose and minerals, which help maintain a proper fluid balance.
O.R.S Hydration Tablets are based on the standard oral rehydration salts formula, helping the body to replenish water and salts that can be lost through exercise, an active lifestyle and hot climates.
Clinova’s products are available in the UK from most major supermarkets and pharmacies and can be purchased in packs of either 12 or 24, in flavours lemon, strawberry and blackcurrant. The products are also available in 20 countries and set to be available in over 40 countries by the end of 2015. Kenya will be the first country in Africa to launch the product later this year.
Director of Research and Development at Clinova, Arsalan Karim, said: “The company has a specific strategy of penetrating the fast-growing Middle East, Africa and Asia-Pacific markets and Africa Health provides us with an great platform to begin achieving this.
“We’re excited by the possibility of expanding our already growing export presence and believe that our O.R.S Hydration Tablets would be beneficial for those living and working in the hot climates in this region.”
Africa Health 2014 will take place from 29-31 May in Johannesburg, South Africa. Clinova will be located at Stand 2J26.
To arrange meetings with Clinova at Africa Health please email Clinova: firstname.lastname@example.orgTags: Clinova, ORS, Press, Update
This post was written by david